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Epidemiological studies indicate that there is an increased likelihood for the development of nicotine addiction when cigarette smoking
starts early during adolescence. These observations suggest that adolescence could be a “critical” ontogenetic period, during which drugs
of abuse have distinct effects responsible for the development of dependence later in life. We compared the long-term behavioral and
molecular effects of repeated nicotine treatment during either periadolescence or postadolescence in rats. It was found that exposure to
nicotine during periadolescence, but not a similar exposure in the postadolescent period, increased the intravenous self-administration
of nicotine and the expression of distinct subunits of the ligand-gated acetylcholine receptor in adult animals. Both these changes
indicated an increased sensitivity to the addictive properties of nicotine. In conclusion, adolescence seems to be a critical developmental
period, characterized by enhanced neurobehavioral vulnerability to nicotine.
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Introduction
Several epidemiological studies indicate that there is an increased
likelihood for the development of nicotine addiction when ciga-
rette smoking starts early during adolescence (Taioli and
Wynder, 1991; Breslau and Peterson, 1996; Kandel and Chen,
2000). These observations suggest that adolescence could repre-
sent a “critical” ontogenetic period. During adolescence, drugs of
abuse may have distinct effects, not yet fully characterized, which
may be responsible for an increased risk to develop drug depen-
dence later in life.
In rodents, periadolescence has been classically defined as the
ontogenetic period that encompasses the 7–10 d preceding the
onset of puberty (at40 d of age) and the first few days thereafter
(Spear and Brake, 1983). This developmental period is character-
ized by specific neurobiological and behavioral features (Stam-
ford, 1989; Teicher et al., 1995; Laviola et al., 1999; Trauth et al.,
1999, 2001; Spear, 2000). The validity of such an animal model
for the purpose of comparison or extrapolation to the human
case has been recently confirmed (Spear, 2000). Compared with
adults, periadolescent rodents show an unbalanced spontaneous
behavior, consisting of increased novelty seeking, decreased
novelty-induced stress and anxiety, as well as elevated levels of
impulsivity and restlessness (Laviola et al., 1999, 2003). As for
psychopharmacological features, after repeated psychostimulant
administration, periadolescent rodents exhibit a greater locomo-
tor sensitization and a less marked place conditioning (Laviola et
al., 1995; Tirelli et al., 2003). Interestingly, they also show a higher
vulnerability to nicotine-induced changes in dopaminergic and
cholinergic functions (Trauth et al., 1999, 2001).
The aim of the present study was to assess whether the mag-
nitude of the long-term effects of nicotine would differ depend-
ing on the age of previous drug exposure. For this purpose, we
compared the self-administration (SA) of nicotine and the ex-
pression of different subunits of the ligand-gated acetylcholine
receptors (nAChRs) in adult rats that had been exposed to the
same regimen of nicotine administration during either periado-
lescence or postadolescence.
The nAChRs were studied because the addictive properties of
nicotine (Stolerman and Shoaib, 1991) are thought to be medi-
ated by activation of the nAChRs (Picciotto et al., 1995) expressed
in the ventral tegmental area (VTA), which induces an increase in
dopamine (DA) release from mesencephalic DA neurons (Pon-
tieri et al., 1996). Gene expression was measured in tissue samples
of the ventral midbrain containing mainly the VTA but also a
small portion of the most medial part of the substantia nigra
(SN). These brain regions contain GABA neurons in addition to
DA neurons. Both types of neurons express two major forms of
the nAChRs (Klink et al., 2001): (1) a homopentamer formed by
five 7 subunits, and (2) a heteropentamer formed by a combi-
nation of  and  subunits, with 4 and 2 being the predomi-
nant ones. The most predominant nAChRs in GABA neurons is
the 4(3)–2(2) type. The nAChRs expressed in DA neurons, in
addition to4 and2, also contain5 and/or6 subunits (Klink
et al., 2001).
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Materials and Methods
Subjects. Sprague Dawley rats (Iffa Credo, St. Germain sur l’Arbresle,
France) were housed with a 12 hr light/dark cycle (lights off at 1:30 P.M.).
Temperature (22  1°C) and humidity (60  5%) were controlled.
Animals had ad libitum access to food and water throughout the experi-
ment. Breeding pairs were formed for 2 weeks, after which the male was
removed, and the females were housed individually. The day of delivery
was considered as postnatal day 0 (P0). On P1, litters were culled to four
males and four females. On P21, rat pups were weaned. Only male sub-
jects were used for the present experiments, and each of the four exper-
imental groups contained one individual per litter. Delivery of animals
within the periadolescent group was planned to occur 25 d after the one
of animals within the postadolescent group. This schedule allowed start-
ing the nicotine and vehicle treatments at the same time in both age
groups.
Surgery. A SILASTIC catheter (internal diameter, 0.28 mm; external
diameter, 0.61 mm; dead volume, 12 l) was implanted in the jugular
vein (Caine et al., 1993; Deroche et al., 1999) under ketamine (100 mg/kg,
i.p.) (Imalgene; Merial, Lyon, France)–xylazine (4 mg/kg, i.p.) (Rompun
2%; Bayer, Leverkusen, Germany) anesthesia. The proximal end was
placed in the right atrium while the distal end was passed under the skin
and fixed in the midscapular region. Rats were allowed to recover for 5–7
d after surgery. During the first 4 d after surgery, rats received an antibi-
otic treatment [gentamycin, 1 mg/kg, i.v. (gentalline 80 mg; Schering-
Plough, Levallois-Perret, France)]. After surgery, catheters were flushed
daily with a saline solution containing unfractionated heparin (100 IU/
ml) (he´parine choay; Sanofi Winthrop, Gentilly, France).
Evaluation of nicotine SA. The intravenous SA setup (Imetronic, Pes-
sac, France) consisted of 16 SA chambers made of Plexiglas and metal.
Each chamber (40-cm-long  30-cm-wide  52-cm-high) was located
within a larger exterior opaque box equipped with exhaust fans that
assured air renewal and masked background noise. Briefly, animals were
placed in a SA chamber where their chronically implanted intravenous
catheter was connected to a pump-driven syringe (infusion speed, 20
l/sec). Two holes, located in opposite sides of the SA chamber at 5 cm
from the grid floor, were used as devices to record responding. A cue light
(1.8 cm in diameter) was located 10.5 cm above one hole.
Daily SA sessions were conducted during the first half of the dark phase
for 1 hr. Introduction of the animal’s nose into one hole (active device)
turned on a cue light located above it and then, 1 sec later, switched on the
infusion pump. The cue light remained on for a total of 4 sec. Each
infusion was followed by a 20 sec time out period during which further
responses in the active hole had no scheduled consequences. Nose pokes
in the other hole (inactive device) never had scheduled consequences.
The self-infusion volume was 20 l and contained 0.04 mg/kg of nico-
tine. A fixed ratio (FR; number of nose pokes necessary to obtain one
infusion of nicotine) was used within each session but was progressively
increased across sessions according to the following progression: FR1,
6 d; FR2, FR3, FR5, 3 d each; FR8, FR10, FR15, FR20, FR25, FR30, 4 d
each. This across sessions progressive ratio (PR) schedule has been de-
scribed as a useful tool to study motivational effects of drugs (Risner and
Goldberg, 1983; Risner and Cone, 1986; Piazza et al., 2000). In particular,
across-sessions PR schedules, as compared with more widely used within-
session schedules, have the advantages to avoid confounding within-session
satiation with cessation in consumption caused by increased ratio response
requirements (Giordano et al., 2001). Experimental contingencies were con-
trolled, and data was collected with a Windows-compatible personal com-
puter software (Imetronic, Pessac, France).
Evaluation of locomotor activity. The locomotor activity setup (Ime-
tronic) consisted of 12 Plexiglas boxes (30-cm-long, 40-cm-high, and
30-cm-wide). Each box was equipped with two computer-monitored
photocell beams separated by 14 cm. Locomotion was estimated by the
number of cage crossings, i.e., consecutive breaks of the two beams. The
test was performed under dim illumination 1 hr and 30 min after the dark
phase started. Animals were placed in the cages immediately after intra-
peritoneal nicotine injection, and locomotor activity was monitored for
15 min.
Evaluation of nAChR gene expression. Animals were killed by decapita-
tion, and their brains were dissected. Samples of the ventral midbrain,
containing mainly the VTA but also a small portion of the most medial
part of the SN, were isolated and stored at 80°C until RNA isolation.
Quantitative PCR was used to evaluate the expression of genes coding for
different nAChR subunits. From each rat, total RNA was isolated (Chom-
czynski and Sacchi, 1987) (30g), and from 50% total RNA, mRNA was
isolated using magnetic beads (Dynal, Great Neck, NY). cDNA was synthe-
sized using hexanucleotide primers and used in quantitative PCR (ABI 7700)
according to the manufacturer’s protocol (Perkin-Elmer). Gene-specific
primers were designed using Primer Express (Perkin-Elmer): Hypoxanthine
guanine phosphoribosyltransferase (HPRT; M63983) sense: 5-ATGG-
GAGGCCATCACATTGT-3, antisense: 5-ATGTAATCCAGCAGGTCA-
GCAA-3;2 subunit sense: 5-CATCCCAGGCTAGCGAGATTC-3, anti-
sense: 5-TCAGACGGTCAGCAATGTAGTGT-3; 3 subunit sense: 5-
CCATGGTGATTGATCGCATCT-3, antisense: 5-GCCATCAAGGGTT-
GCAGAA-3; 4 subunit sense: 5-GAAGGCGTCCAGTACATTGCA-3,
antisense: 5-GGCCACGTATTTCCAGTCCTC-3; 5 subunit sense: 5-
GCTGGATACGGTGCCTCATAC-3, antisense: 5-CCAGGCTGACCA-
ACAACTCAC-3; 6 subunit sense: 5-CAAGTGAGATAGCACCTGG-
CAAG-3, antisense: 5-CATCAGGTGGGTGCTCTGAA-3; 7 subunit
sense: 5-ATGTGCAAGAGTGCCTTCGTG-3, antisense: 5-CCTGATT-
GGTCGCTTACCCAT-3; 2 subunit sense: 5-CAGTACTGGGTGC-
AAGATGGATC-3, antisense: 5-AGGCTGGAGGACTATGTGTGAAC-
3; 3 subunit sense: 5-TGCAGGGCACTGAGAGAATG-3, antisense:
5-CGTCTCCAAATTGCCCAACT-3; 4 subunit sense: 5-CACCAGC-
ACCTTGCCCATA-3, antisense: 5-TGGGTCCCAAGCTCTGGAG-3.
The efficiency of amplification of each primer set was tested and used only
if2. Measurements were performed in duplicate.
Protocol. 96 animals were administered intraperitoneally with either
nicotine (0.4 mg/kg; n  48) or vehicle (0.9% saline solution; n  48)
once per day for 10 d. The periadolescent group was treated from P34 to
P43. The postadolescent group received an identical treatment between
P60 and P69. This period was chosen because it is intermediate between
periadolescence and P75, the age that is used for most studies in adult
rats. Five weeks later, i.e., at an age when both groups were adults, ani-
mals were used either for nicotine SA, evaluation of nAChR gene expres-
sion, or evaluation of nicotine-induced locomotor activity.
Thirty-two littermates were used for nicotine SA [16 nicotine pre-
treated (n  8 for each age group) and 16 vehicle pretreated (n  8 for
each age group)]. Sixteen littermates were used for evaluation of nAChR
gene expression [8 nicotine pretreated (n 4 for each age group) and 8
vehicle pretreated (n  4 for each age group)]. In a supplementary ex-
periment, 48 littermates [24 nicotine pretreated (n  12 for each age
group) and 24 vehicle pretreated (n  12 for each age group)] were
treated either with saline or nicotine following an identical schedule. This
time, after a 5 week drug-free period, they received an intraperitoneal
injection of nicotine and were tested for the locomotor response to the
drug. In each experimental group, half of the animals were tested with 0.3
mg/kg of nicotine, whereas the other half was tested with 0.6 mg/kg of
nicotine. This experiment was aimed to control for a potential difference
in locomotor sensitization between the periadolescent and postadoles-
cent groups that could account for the observed differences in SA
behavior.
Statistical analyses. For behavioral studies, all data were analyzed using
ANOVA. For acquisition of nicotine SA, active and inactive responses
during the first 15 d (up to FR5) were used as dependent variables. For the
PR study, the number of active nose pokes during the last 2 d at each FR
were used as the dependent variable. For nicotine-induced locomotor
activity, total activity over the 15 min of the test was used as the depen-
dent variable. Age of pretreatment (periadolescent–postadolescent) and
treatment (vehicle–nicotine pretreatment) were used as between-subject
factors. Time (number of sessions or number of ratios) and hole (active–
inactive) were used as within-subject factors.
For gene expression, cycle threshold values were used to calculate
differences in expression levels after correction for tissue input by the
HPRT control. Student’s t tests were performed to analyze the statistical
differences.
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Results
Nicotine SA
Three animals were excluded from the study because of catheter
failure (one in the periadolescent nicotine-pretreated group and
two in the periadolescent vehicle-pretreated group).
Pretreatment with nicotine during periadolescence, but not
during postadolescence, increased nicotine SA in adult subjects.
Thus, when compared with animals that received a pretreatment
with vehicle, adult animals pretreated with nicotine during peri-
adolescence showed an increased number of responses for the
drug during the whole acquisition period (Fig. 1). These animals
also showed increased motivation to self-administer nicotine, in
that they showed a higher rate of responding for the drug over a
broader range of ratios than did animals pretreated with nicotine
during the postadolescent period (Fig. 2). The latter group, com-
pared with vehicle-pretreated controls, showed a transient in-
crease in responding that was only observed during the first few
days of SA corresponding to the lowest ratio requirement (Fig. 1,
FR1). After this period, animals pretreated with nicotine during
the postadolescent period never differed from vehicle-pretreated
controls (Figs. 1, 2). Differences in nicotine SA between periado-
lescent and postadolescent pretreated rats could not rely on dif-
ferences in age of testing (11 and 15 weeks, respectively) because
periadolescent and postadolescent vehicle-pretreated animals
did not differ for nicotine SA. Similarly, differences in SA be-
tween nicotine-pretreated periadolescent and postadolescent rats
do not seem to depend on differences in the locomotor stimulant
effects of nicotine. Indeed, animals receiving an identical nicotine
pretreatment during either periadolescence or postadolescence
did not differ for the locomotor response to nicotine when tested
5 weeks later. Both groups showed a sensitized response to acute
nicotine, when compared with the vehicle-pretreated animals
(treatment effect, F(1,52)  10.4; p  0.005), but no age-related
differences were evidenced (treatment  age interaction,
F(1,52)  0.0004; p  0.98). Whatever the dose tested, the two
nicotine-pretreated groups showed a similar nicotine-induced
activation, independently from age of pretreatment [age effect,
F(1,13) 0.074; p 0.78 for 0.3 mg/kg; F(1,13) 0.51; p 0.48 for
0.6 mg/kg; data not shown).
nAchR gene expression
In adult subjects pretreated with nicotine during periadoles-
cence, an increase in gene expression of the DA neuron-specific
subunits (5 and 6) and of the 2 subunit was found. In con-
trast, no significant changes were found in the transcript levels of
the other  subunits (Fig. 3). Moreover, a significant upregula-
tion of the 3 subunit was found in animals receiving nicotine
during both postadolescence and periadolescence. Finally,
mRNA levels for the 2 and 4 subunits were not reliably
detected.
Discussion
Taken together, the results of the acquisition experiment and of
the PR schedule indicate that animals pretreated with nicotine
Figure 1. Animals pre-exposed to nicotine during periadolescence (right panel) and post-
adolescence (left panel) differed during acquisition of nicotine SA (age treatment day
interaction, F(14,350) 1.80; p 0.05). Within the periadolescent group, nicotine-pretreated
animals showed more nose pokes in the active device delivering nicotine (0.04 mg/kg per
infusion) than did vehicle-pretreated controls, and this during the entire acquisition period
(treatment effect, F(1,11)  4.64; p  0.05). Conversely, within the postadolescent group,
nicotine-pretreated animals showed more active nose pokes than vehicle-pretreated controls,
only during the FR1 period (treatment day hole interaction, F(14,196) 2.03; p 0.05).
The two groups did not differ anymore when the FR requirement was increased over days. The
two vehicle-pretreated groups did not differ at any time (age effect, F(1,12) 2.28; p 0.6).
Responses in the inactive device had no schedule consequences and were used as a control of
SA. The two age groups (periadolescent and postadolescent) did not differ for the number of
inactive responses. Similarly, in both age groups, vehicle-treated and nicotine-pretreated ani-
mals did not differ for inactive responses. FR indicates the number of active responses necessary
to obtain one infusion of nicotine. *p  0.05 in comparison with corresponding vehicle-
pretreated animals.
Figure 2. Animals pre-exposed to nicotine during periadolescence and postadolescence dif-
fered during a between session PR schedule for nicotine SA. FR indicates the number of re-
sponses necessary to obtain one infusion of nicotine. Because animals pretreated with vehicle
during either periadolescence or postadolescence did not differ (F(1,12) 2.28; p 0.60), they
were collapsed in the vehicle group. In the postadolescent group, the number of responses in
the active device delivering nicotine (0.04 mg/kg per infusion) did not differ between animals
pretreated with nicotine and animals pretreated with vehicle, with the exception of FR1 (Fig. 1).
In these two groups, responses increased regularly up to FR10 and progressively decreased at
FR20, 25, and 30, providing the typical bell-shaped curve observed with this PR schedule. In
animals pretreated with nicotine during periadolescence, no significant decrease in response
was observed up to FR30, these animals showing a higher number of active responses than the
other two groups at FR20, 25, and 30( p 0.05).
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during periadolescence become more sensitive to the reinforcing
effects of this drug. Thus, a higher drug intake during acquisition
and a higher performance in a PR schedule have been associated
with a higher reinforcing efficacy of the drug (Piazza et al., 2000).
The increase in the motivational properties of drugs after their
repeated administration is a phenomenon, defined sensitization,
that is considered to be one of the major processes leading to
addiction (Robinson and Berridge, 1993). Indeed, it has been
repeatedly shown that, in adult animals, pre-exposure to various
drugs of abuse, and in particular to psychostimulants like am-
phetamine and cocaine, facilitates the acquisition of SA and in-
creases the motivational performance in PR schedules of rein-
forcement (Piazza et al., 1990; Pierre and Vezina, 1997; Schenck
and Partridge, 1997). So far, nicotine was an exception in this
respect. Namely, pretreatment with this drug during adulthood
induced only a transient facilitation of SA behavior (Shoaib et al.,
1997), very similar to the one that we describe here for postado-
lescent rats. Interestingly, our data demonstrate that nicotine can
actually induce a clear-cut sensitization in a manner that is sim-
ilar to other drugs of abuse, but only if it is administered during
periadolescence.
These behavioral effects of nicotine, which are so highly spe-
cific to the adolescent period, were also associated with very spe-
cific changes in transcript levels of nAChR subunits. In adult
subjects pretreated with nicotine during periadolescence, an in-
crease in gene expression of the 5, 6, and 2 subunits was
found. Probably, this increase occurred specifically in DA neu-
rons, because they are the only cell type-expressing receptors that
include the 5 and/or 6 subunits (Klink et al., 2001). These
changes, if they were translated in an increase in protein levels,
might have contributed to an increased vulnerability to nicotine
in the periadolescent group. Indeed, a deletion of the 2 subunit
in 2/mice abolishes both nicotine-induced DA release and
nicotine SA (Picciotto et al., 1995; Lena and Changeux, 1999).
Hence, the upregulation of mRNA for the 2 subunit may sug-
gest relatively higher levels of the heteropentameric receptors,
which in turn may explain the increased reinforcing effects of
nicotine.
The upregulation of mRNAs coding for the 5 and the 6
subunits suggest that the heteropentameric nAChRs were up-
regulated and/or became more sensitive to nicotine. Indeed, the
incorporation of an 5 subunit into 32 receptors leads to a
50-fold increase in sensitivity to nicotine (Gerzanich et al., 1998;
Nelson and Lindstrom, 1999; Kuryatov et al., 2000). Similarly,
the inclusion of an 6 subunit into 32 receptors renders the
heteropentamer less responsive to acetylcholine (the endogenous
ligand), but increases the potency and efficacy of nicotine, i.e., it
turns nicotine into a full agonist instead of a partial agonist
(Kuryatov et al., 2000). On this line, it has been shown that block-
ade of 6 subunit expression, through injections of antisense
oligonucleotides in the VTA, blocks the stimulant effects of nic-
otine (Le Novere et al., 1999). All these evidences support the
hypothesis that an enhanced sensitivity to the reinforcing effects
of nicotine may follow an increase in 5 and 6 subunit tran-
script levels.
A significant upregulation of the 3 subunit was found in
animals receiving nicotine during both postadolescence and peri-
adolescence. Little is known about the functional role of this
subunit. However, its selective increase does not seem to be ac-
companied by major changes in nicotine SA, as observed in the
postadolescent group. Finally, our study agrees with observations
showing that 2 and 4 subunits are not expressed in the ventral
midbrain (Klink et al., 2001) because we could not reliably detect
mRNA levels for these subunits.
The results of the present experiments suggest that periado-
lescence is a critical developmental period, during which expo-
sure to nicotine induces behavioral and molecular changes that
are strikingly different from those observed in subjects exposed to
the same drug but later in life. Furthermore, these distinct mo-
lecular changes seem compatible with an increased sensitivity to
the addictive effects of nicotine. The mechanisms by which nic-
otine can have differential effects on the postadolescent and the
periadolescent brain cannot be precisely defined at this stage and
certainly deserve further investigations. However, different levels
of maturation of the CNS, and consequently different sensitivity
of the genome to external stimuli are probably implicated.
Indeed, studies on the adolescent brain have shown that active
cell replication and remodeling of synapses occur prominently
during this period (Spear, 2000). DA and noradrenergic systems
show large changes in neurotransmitter levels and activity during
adolescence (Loizou, 1972; Segawa, 2000). In particular, a re-
duced basal rate of DA release and a reduced pool of readily
releasable DA have been reported in periadolescent rats (Stam-
ford, 1989). Also, DA receptors and nAChRs are overexpressed in
rat brain throughout adolescence, because they undergo pro-
grammed pruning thereafter (Naeff et al., 1992; Teicher et al.,
1995; Andersen et al., 1997). Finally, and consistent with our
data, it has been recently shown that the long-term consequences
of a nicotine pretreatment are more marked and persistent with
adolescent than with adult exposure (Trauth et al., 1999, 2001).
In conclusion, adolescence seems to be a critical developmen-
tal period, characterized by a neurobehavioral vulnerability to
nicotine. Specifically, nicotine exposure during adolescence may
render an individual more vulnerable to its addictive properties.
Recently, an increased vulnerability to nicotine consumption has
been also shown during early adolescence in mice (Adriani et al.,
2002). Consequently, the analysis of the mechanisms rendering
the adolescent brain so vulnerable to nicotine in particular and to
drugs of abuse in general could open new avenues for the under-
standing of drug dependence.
Figure 3. Animals pre-exposed to nicotine during periadolescence and postadolescence dif-
fered for transcript levels of different subunits of the nAChRs in the ventral midbrain. Results are
expressed as fold changes from the matched vehicle-pretreated controls. An upregulation of the
5, 6, and 2 subunits was found in animals pretreated with nicotine during periadoles-
cence. In contrast, no significant changes were found in animals that received the same nicotine
pretreatment but during postadolescence, with the exception of the3 subunit that was sim-
ilarly increased in both groups. **p 0.001 in comparison with animals pretreated during
postadolescence.
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